The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
High-Risk Features and Tumor Differentiation in Retinoblastoma: A Retrospective Histopathologic Study
Abstract
Context. —Certain histopathologic risk factors in enucleated eyes are important indicators for adjuvant chemotherapy in patients with retinoblastoma. Objectives. —To determine the frequency of histopathologic risk factors in a large series of retinoblastomas treated by enucleation on file in the pathology laboratory of a large American eye hospital, assess the relationship between tumor differentiation and age at enucleation, and investigate the frequency of photoreceptor differentiation and the role of retinoma/retinocytoma as retinoblastoma precursor. Design. —Retrospective histopathologic review of 387 eyes with retinoblastoma treated by enucleation including 297 with no prior treatment. Results. —Fifty-five of 297 untreated eyes (18.5%) had high-risk features. Retrolaminar optic nerve invasion was present in 31 (10.4%), and 24 (8.1%) had massive uveal invasion (defined as >3 mm in diameter). Of the high-risk eyes, 70.9% had iris neovascularization and 60% had neovascular glaucoma. There was a statistically significant inverse relationship between age at enucleation and the degree of tumor differentiation, evidenced by the presence of rosettes. Tumors in older children tended to be poorly differentiated, while rosettes were often numerous in the tumors of younger infants. In all, 20.4% of tumors contained foci of photoreceptor differentiation, which localized in the base of a predominantly endophytic tumor in about one-fourth. Lack of correlation between photoreceptor differentiation and age at enucleation is consistent with early or prenatal malignant transformation. Both preceding observations provide evidence for the hypothetical role of retinoma as a retinoblastoma precursor. Conclusions. —Slightly less than 1 in 5 infants with retinoblastoma treated by enucleation at a large American eye hospital would require adjuvant chemotherapy on the basis of existing high-risk histopathologic features. Retinoblastomas become progressively less differentiated with time and may be spawned by precursor retinomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dimaras, H., Khetan, V., Halliday, W., Orlic, M., Prigoda, N. L., Piovesan, B., Marrano, P., Corson, T. W., Eagle, R. C., Squire, J. A., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn024 · Cited by 351
Self-citation
Cited by
Intra-arterial Chemotherapy for Retinoblastoma: A Systematic Review
Yousef, Y. A., Soliman, S. E., Astudillo, P. P. P., Durairaj, P., Dimaras, H., Chan, H. S. L., Héon, E., Gallie, B. L., & Shaikh, F. (2016) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2016.0244 · Cited by 370
Shields, C. L., & Shields, J. A. (2010) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e328338676a · Cited by 280
Metadata
- Authors
- Eagle Jr, R. C.
- Venue
- Archives of Pathology & Laboratory Medicine
- Published
- 2009-08
- Volume
- 133
- Issue
- 8
- Pages
- 1203-1209
- ISSN
- 0003-9985 (ISSN-L)
- 1543-2165
- OpenAlex
- W2136670281
- Cited by
- 176
- References
- 1
- FWCI
- 10.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High-Risk Features and Tumor Differentiation in Retinoblastoma: A Retrospective Histopathologic Study. https://app.cochat.ai/papers/10.5858/133.8.1203
- The paper
- Eagle Jr, R. C. (2009). High-Risk Features and Tumor Differentiation in Retinoblastoma: A Retrospective Histopathologic Study. Archives of Pathology & Laboratory Medicine. https://doi.org/10.5858/133.8.1203
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.